Skip to main content

Mariette DiChristina

Precision Medicine: Progress and Promise

By Insights

As genomic technologies move from lab to clinic, how can business and government bridge the gap between availability and access?

Dimensions to be addressed:

  • Health system infrastructure
  • Data on clinical and cost effectiveness
  • Lagging insurance models


  • Jay Flatley, Executive Chairman, Illumina, USA.
  • Elisabet de los Pinos Pont, Founder and Chief Executive Officer, Aura Biosciences, USA.
  • Wang Jian, President and Co-Founder, BGI, People’s Republic of China.

Moderated by: – Mariette DiChristina, Editor-in-Chief, Scientific American, USA.